Skip to main content
OpenTrials

Clinical trial condition

Esophageal Neoplasms

Explore clinical trials studying Esophageal Neoplasms. Study availability and eligibility vary by location and protocol.

1,256 public trials 320 recruiting studies
Refine in advanced search Browse all conditions

Esophageal Neoplasms trial results

Recruiting

DESTINY-PANTUMOUR04

NCT07124000

Conditions
Adenocarcinoma, Adenocarcinoma (NOS), Adnexal Diseases, +116 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Bullhead City, Arizona, United States
  • Research Site Casa Grande, Arizona, United States
  • Research Site San Diego, California, United States
View all 18 locations
View Trial Details
Recruiting

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT06172478

Conditions
Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +70 more
Locations
  • City of Hope Duarte, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • AdventHealth Medical Group Oncology Research at Celebration Kissimmee, Florida, United States
  • University of Illinois Cancer Center Chicago, Illinois, United States
View all 91 locations
View Trial Details
Recruiting

A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

NCT06123338

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +9 more
Locations
  • Massachusetts General Hospital (Data Collection Only) Boston, Massachusetts, United States
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
View Trial Details
Recruiting

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

NCT06047379

Conditions
Adenocarcinoma, Astrocytoma, Brain Diseases, +93 more
Locations
  • Precision NextGen Oncology Beverly Hills, California, United States
  • OPN Healthcare, Inc Glendale, California, United States
  • University of Southern California Los Angeles, California, United States
  • MDR Core Network Boynton Beach, Florida, United States
View Trial Details
Recruiting

Pan-tumor MRD Study

NCT06605404

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +34 more
Locations
  • Medical Oncology Associates of San Diego San Diego, California, United States
  • Taylor Cancer Research Center Maumee, Ohio, United States
  • Alabama Oncology Birmingham, Alabama, United States
  • Mohtaseb Cancer Center and Blood Disorders Bullhead City, Arizona, United States
View all 47 locations
View Trial Details
Recruiting

sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE)

NCT05332002

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +7 more
Locations
  • RWJBarnabas Health - Robert Wood Johnson University Hospital Hamilton, New Jersey, United States
  • RWJBarnabas Health - Monmouth Medical Center Southern Campus Lakewood, New Jersey, United States
  • RWJBarnabas Health - Monmouth Medical Center Long Branch, New Jersey, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
View Trial Details
Recruiting

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

NCT07114601

Conditions
Breast Diseases, Breast Neoplasms, Colonic Diseases, +37 more
Locations
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles (UCLA) Santa Monica, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Biogenix Molecular, LLC Miami, Florida, United States
View all 33 locations
View Trial Details
Recruiting

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

NCT06128551

Conditions
Adenocarcinoma, Adnexal Diseases, Appendiceal Neoplasms, +59 more
Locations
  • City of Hope Duarte, California, United States
  • UC IRVINE Health Orange, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • Stanford Cancer Institute Stanford, California, United States
View all 56 locations
View Trial Details
Recruiting

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

NCT07213791

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +39 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Biogenix Molecular, LLC Miami, Florida, United States
  • Moffitt Tampa, Florida, United States
View all 30 locations
View Trial Details

Related conditions